@phdthesis{Kiser2019,
  author    = {Kiser, Dominik Pascal},
  title     = {Gene x Environment Interactions in Cdh13-deficient Mice: CDH13 as a Factor for Adaptation to the Environment},
  doi       = {10.25972/OPUS-17959},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-179591},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are disorders of mostly unknown etiopathogenesis, for which both genetic and environmental influences are expected to contribute to the phenotype observed in patients. Changes at all levels of brain function, from network connectivity between brain areas, over neuronal survival, synaptic connectivity and axonal growth, down to molecular changes and epigenetic modifications are suspected to play a key roles in these diseases, resulting in life-long behavioural changes. Genome-wide association as well as copy-number variation studies have linked cadherin-13 (CDH13) as a novel genetic risk factor to neuropsychiatric and neurodevelopmental disorders. CDH13 is highly expressed during embryonic brain development, as well as in the adult brain, where it is present in regions including the hippocampus, striatum and thalamus (among others) and is upregulated in response to chronic stress exposure. It is however unclear how CDH13 interacts with environmentally relevant cues, including stressful triggers, in the formation of long-lasting behavioural and molecular changes. It is currently unknown how the environment influences CDH13 and which long term changes in behaviour and gene expression are caused by their interaction. This work therefore investigates the interaction between CDH13 deficiency and neonatal maternal separation (MS) in mice with the aim to elucidate the function of CDH13 and its role in the response to early-life stress (ELS). For this purpose, mixed litters of wild-type (Cdh13+/+), heterozygous (Cdh13+/-) and homozygous knockout (Cdh13-/-) mice were maternally separated from postnatal day 1 (PN1) to postnatal day 14 (PN14) for 3 hours each day (180MS; PN1-PN14). In a first series of experiments, these mice were subjected to a battery of behavioural tests starting at 8 weeks of age in order to assess motor activity, memory functions as well as measures of anxiety. Subsequently, expression of RNA in various brain regions was measured using quantitativ real-time polymerase chain reaction (qRT-PCR). A second cohort of mice was exposed to the same MS procedure, but was not behaviourally tested, to assess molecular changes in hippocampus using RNA sequencing. Behavioural analysis revealed that MS had an overall anxiolytic-like effect, with mice after MS spending more time in the open arms of the elevated-plus-maze (EPM) and the light compartment in the light-dark box (LDB). As a notable exception, Cdh13-/- mice did not show an increase of time spent in the light compartment after MS compared to Cdh13+/+ and Cdh13+/- MS mice. During the Barnes-maze learning task, mice of most groups showed a similar ability in learning the location of the escape hole, both in terms of primary latency and primary errors. Cdh13-/- control (CTRL) mice however committed more primary errors than Cdh13-/- MS mice. In the contextual fear conditioning (cFC) test, Cdh13-/- mice showed more freezing responses during the extinction recall, indicating a reduced extinction of fear memory. In the step-down test, an impulsivity task, Cdh13-/- mice had a tendency to wait longer before stepping down from the platform, indicative of more hesitant behaviour. In the same animals, qRT-PCR of several brain areas revealed changes in the GABAergic and glutamatergic systems, while also highlighting changes in the gatekeeper enzyme Glykogensynthase-Kinase 3 (Gsk3a), both in relation to Cdh13 deficiency and MS. Results from the RNA sequencing study and subsequent gene-set enrichment analysis revealed changes in adhesion and developmental genes due to Cdh13 deficiency, while also highlighting a strong link between CDH13 and endoplasmatic reticulum function. In addition, some results suggest that MS increased pro-survival pathways, while a gene x environment analysis showed alterations in apoptotic pathways and migration, as well as immune factors and membrane metabolism. An analysis of the overlap between gene and environment, as well as their interaction, highlighted an effect on cell adhesion factors, underscoring their importance for adaptation to the environment. Overall, the stress model resulted in increased stress resilience in Cdh13+/+ and Cdh13+/- mice, a change absent in Cdh13-/- mice, suggesting a role of CDH13 during programming and adaptation to early-life experiences, that can results in long-lasting consequences on brain functions and associated behaviours. These changes were also visible in the RNA sequencing, where key pathways for cell-cell adhesion, neuronal survival and cell-stress adaptation were altered. In conclusion, these findings further highlight the role of CDH13 during brain development, while also shedding light on its function in the adaptation and response during (early life) environmental challenges.},
  subject      = {Cadherine},
  language  = {en}
}
@article{HolubyevBratengeierGaineyetal.2013,
  author    = {Holubyev, Konstyantyn and Bratengeier, Klaus and Gainey, Mark and Polat, B{\"u}lent and Flentje, Michael},
  title     = {Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases},
  series = {Radiation Oncology},
  journal   = {Radiation Oncology},
  doi       = {10.1186/1748-717X-8-263},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-96818},
  year      = {2013},
  abstract  = {Background The standard clinical protocol of image-guided IMRT for prostate carcinoma introduces isocenter relocation to restore the conformity of the multi-leaf collimator (MLC) segments to the target as seen in the cone-beam CT on the day of treatment. The large interfractional deformations of the clinical target volume (CTV) still require introduction of safety margins which leads to undesirably high rectum toxicity. Here we present further results from the 2-Step IMRT method which generates adaptable prostate IMRT plans using Beam Eye View (BEV) and 3D information. Methods Intermediate/high-risk prostate carcinoma cases are treated using Simultaneous Integrated Boost at the Universit{\"a}tsklinkum W{\"u}rzburg (UKW). Based on the planning CT a CTV is defined as the prostate and the base of seminal vesicles. The CTV is expanded by 10 mm resulting in the PTV; the posterior margin is limited to 7 mm. The Boost is obtained by expanding the CTV by 5 mm, overlap with rectum is not allowed. Prescription doses to PTV and Boost are 60.1 and 74 Gy respectively given in 33 fractions. We analyse the geometry of the structures of interest (SOIs): PTV, Boost, and rectum, and generate 2-Step IMRT plans to deliver three fluence steps: conformal to the target SOIs (S0), sparing the rectum (S1), and narrow segments compensating the underdosage in the target SOIs due to the rectum sparing (S2). The width of S2 segments is calculated for every MLC leaf pair based on the target and rectum geometry in the corresponding CT layer to have best target coverage. The resulting segments are then fed into the DMPO optimizer of the Pinnacle treatment planning system for weight optimization and fine-tuning of the form, prior to final dose calculation using the collapsed cone algorithm. We adapt 2-Step IMRT plans to changed geometry whilst simultaneously preserving the number of initially planned Monitor Units (MU). The adaptation adds three further steps to the previous isocenter relocation: 1) 2-Step generation for the geometry of the day using the relocated isocenter, MU transfer from the planning geometry; 2) Adaptation of the widths of S2 segments to the geometry of the day; 3) Imitation of DMPO fine-tuning for the geometry of the day. Results and conclusion We have performed automated 2-Step IMRT adaptation for ten prostate adaptation cases. The adapted plans show statistically significant improvement of the target coverage and of the rectum sparing compared to those plans in which only the isocenter is relocated. The 2-Step IMRT method may become a core of the automated adaptive radiation therapy system at our department.},
  language  = {en}
}
@phdthesis{Bieringer2014,
  author    = {Bieringer, Maria},
  title     = {Analyse der Speziesbarriere humaner Zellen gegen{\"u}ber Infektion mit Hundestaupevirus (CDV)},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-97725},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2014},
  abstract  = {Die geplante Ausrottung der Masern bis 2020 und die damit eventuell einhergehende Beendigung der Masernimpfung k{\"o}nnten die Voraussetzungen daf{\"u}r schaffen, dass andere Morbilliviren, wie beispielsweise das Hundestaupevirus (CDV), einen Wirtswechsel zum Menschen vollbringen k{\"o}nnten. CDV ist ein hoch ansteckendes Pathogen und besitzt einen weiten Wirtstropismus, der sich aktuell immer weiter ausbreitet. Im Gegensatz dazu kann das Masernvirus (MV) nahezu ausschließlich Menschen und nur sehr bedingt wenige Affenarten infizieren. In dieser Doktorarbeit konnte gezeigt werden, dass eine Adaptierung des rekombinanten wildtypischen CDV-Stammes CDV-75/17red an den humanen Rezeptor SLAM (signaling lymphocytic activation molecule, CD150) reproduzierbar und innerhalb weniger Passagen erfolgt. Bei der Adaptierung an das humane SLAM ist dabei nur eine Mutation in dem Gen f{\"u}r das virale H{\"a}magglutinin notwendig. Diese Mutation an Position 8697 von A zu G im viralen Genom (Aminos{\"a}ure D540G im H{\"a}magglutinin) konnte reproduzierbar detektiert werden, obwohl ver{\"o}ffentlicht wurde, dass unterschiedliche Mutationen im H{\"a}magglutinin verschiedener CDV-St{\"a}mme eine SLAM-Adaptierung erm{\"o}glichen. Die Mutation D540G im H{\"a}magglutinin des humanen SLAM-adaptierten CDV-A75/17red kompensiert eine negative Ladung der Aminos{\"a}ure 71E, die speziesspezifisch im humanen SLAM vorhanden ist. Durch Wachstumskinetiken konnte belegt werden, dass das an humanes SLAM-adaptierte CDV-A75/17red auch weiterhin das canine SLAM effizient verwendet. Ein weiterer Eintrittsrezeptor, humanes Nectin4, konnte mit demselben CDV-Stamm ohne adaptive Mutation in den viralen H{\"u}llproteingenen benutzt werden. Wachstumskurven auf verschiedenen humanen B-Lymphozyten Zelllinien zeigen allerdings, dass eine alleinige Adaptierung an die humanen Wirtszellrezeptoren, f{\"u}r eine effiziente Virusreplikation, nicht ausreicht. Damit das CDV die Speziesbarriere durchbrechen kann, muss offenbar ein weiterer Adaptierungsprozess an die humanen Wirtszellen erfolgen, der voraussichtlich mit umfangreicheren Mutationen des viralen Genoms einhergehen w{\"u}rde. Diese Ergebnisse unterstreichen, dass intrinsische Faktoren und das angeborene Immunsystem eine wichtige Barriere bilden und den Menschen vor einer CDV-Infektion sch{\"u}tzen. Allerdings w{\"u}rde eine Fortf{\"u}hrung der MV-Impfung auch nach Ausrottung der Masern, aufgrund der Kreuzreaktivit{\"a}t gegen andere Morbilliviren, den Schutz vor einer m{\"o}glichen Adaptierung eines Morbillivirus, wie CDV, an den Menschen deutlich verst{\"a}rken.},
  subject      = {Staupevirus},
  language  = {de}
}